Nachshonim, Israel

Omer Eilon


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Omer Eilon: Innovator in Vascular Access Technology

Introduction

Omer Eilon is a notable inventor based in Nachshonim, Israel. He has made significant contributions to the field of medical technology, particularly in vascular access devices. His innovative approach has led to the development of a unique patent that enhances the functionality of vascular access wires.

Latest Patents

Omer Eilon holds a patent for a vascular access wire tip comprising a crank. This invention includes an elongated core member and a distal tip. The distal tip is designed with a crank that features a crank distal surface and a crank center of rotation. The crank is engineered to rotate around the crank center of rotation when the core member is subjected to sufficient axial load. This mechanism allows the crank distal surface to press against the wall of a target blood vessel, thereby triggering or affecting the deflection and/or deformation of the core member proximally to the crank. Omer Eilon's patent represents a significant advancement in the design of vascular access devices.

Career Highlights

Omer Eilon is currently associated with Embrace Medical Ltd., where he continues to innovate in the medical technology sector. His work focuses on improving vascular access techniques, which are crucial for various medical procedures. His dedication to enhancing patient care through technology is evident in his contributions to the field.

Collaborations

Omer collaborates with Michael Gabriel Tal, who is also involved in the development of medical technologies. Their partnership aims to push the boundaries of innovation in the healthcare industry.

Conclusion

Omer Eilon's contributions to vascular access technology through his patent and work at Embrace Medical Ltd. highlight his commitment to improving medical devices. His innovative spirit continues to drive advancements in the field, ultimately benefiting patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…